Vertex Pharmaceuticals (VRTX) has a market capitalization of $125.6B, based on 257.08M shares at a price of $488.67 (down 0.8% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
April 2025 | $492.47 | 29,192,798 | 257,080,986 | $126,604,673,175.42 |
March 2025 | $484.82 | 29,023,147 | 260,500,000 | $126,295,610,000.00 |
February 2025 | $479.79 | 27,455,500 | 260,500,000 | $124,985,295,000.00 |
January 2025 | $461.68 | 31,738,600 | 260,500,000 | $120,267,640,000.00 |
December 2024 | $402.70 | 38,615,700 | 260,500,000 | $104,903,350,000.00 |
November 2024 | $468.13 | 28,840,500 | 260,500,000 | $121,947,865,000.00 |
October 2024 | $475.98 | 23,165,500 | 260,500,000 | $123,992,790,000.00 |
September 2024 | $465.08 | 20,105,700 | 261,000,000 | $121,385,880,000.00 |
August 2024 | $495.89 | 26,957,100 | 261,000,000 | $129,427,290,000.00 |
July 2024 | $495.72 | 21,576,794 | 261,000,000 | $129,382,920,000.00 |
June 2024 | $468.72 | 25,825,900 | 258,100,000 | $120,976,632,000.00 |
May 2024 | $455.34 | 26,598,400 | 258,100,000 | $117,523,254,000.00 |
April 2024 | $392.81 | 21,205,000 | 258,100,000 | $101,384,261,000.00 |
March 2024 | $418.01 | 20,143,600 | 261,100,000 | $109,142,411,000.00 |
February 2024 | $420.74 | 28,911,482 | 261,100,000 | $109,855,214,000.00 |
January 2024 | $433.38 | 31,115,550 | 261,100,000 | $113,155,518,000.00 |
December 2023 | $406.89 | 31,205,850 | 260,900,000 | $106,157,601,000.00 |
November 2023 | $354.81 | 32,039,500 | 260,900,000 | $92,569,929,000.00 |
October 2023 | $362.11 | 25,440,700 | 260,900,000 | $94,474,499,000.00 |
September 2023 | $347.74 | 17,966,230 | 260,600,000 | $90,621,044,000.00 |
August 2023 | $348.34 | 19,630,060 | 260,600,000 | $90,777,404,000.00 |
July 2023 | $352.34 | 23,074,230 | 260,600,000 | $91,819,804,000.00 |
June 2023 | $351.91 | 27,039,430 | 260,400,000 | $91,637,364,000.00 |
May 2023 | $323.57 | 29,317,180 | 260,400,000 | $84,257,628,000.00 |
April 2023 | $340.73 | 19,792,810 | 260,400,000 | $88,726,092,000.00 |
